Sign In
NYSE:INO
Inovio Pharmaceuticals Stock News
$4.02
-0.110 (-2.66%)
At Close: Dec 05, 2024
Data from a retrospective trial evaluating the longer-term benefit of INO-3107 to patients with Recurrent Respiratory Papillomatosis (RRP) involved in a Phase 1/2 trial showed the number of patients w
INOVIO Reports Inducement Grant Under Inducement Plan
04:02pm, Friday, 29'th Nov 2024
PLYMOUTH MEETING, Pa. , Nov. 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-r
European And US Vaccine Stocks Are Under Pressure - Here's WHy
11:21am, Friday, 15'th Nov 2024
Some large European and U.S. vaccine maker stocks have fallen in reaction to Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services.
Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript
07:53pm, Thursday, 14'th Nov 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q3 2024 Earnings Call Transcript November 14, 2024 4:30 PM ET Company Participants Thomas Hong - Manager of IR Jacqui Shea - President and CEO Mike Sumner -
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
04:05pm, Thursday, 14'th Nov 2024
New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell respo
New immunology data shows INO-3107 induced an expansion of new clonal T cells in blood that were not detectable prior to treatment New clonal T cells in the blood travelled to papilloma and airway tis
INOVIO to Present at Upcoming Scientific Conferences
04:05pm, Wednesday, 06'th Nov 2024
PLYMOUTH MEETING, Pa. , Nov. 6, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rela
INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
08:00am, Wednesday, 06'th Nov 2024
PLYMOUTH MEETING, Pa. , Nov. 6, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-as
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
08:00am, Monday, 21'st Oct 2024
American Association for Cancer Research (AACR) Special Conference: Tumor Immunology and Immunotherapy : New immunology data showed ability of INO-3107 to induce an antigen-specific T cell response ag
Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains?
06:41am, Wednesday, 09'th Oct 2024
Inovio (INO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
INOVIO Reports Inducement Grants Under Inducement Plan
04:15pm, Wednesday, 02'nd Oct 2024
PLYMOUTH MEETING, Pa. , Oct. 2, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
INOVIO to Present at Upcoming Scientific Conferences
08:00am, Tuesday, 01'st Oct 2024
PLYMOUTH MEETING, Pa. , Oct. 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rela
INOVIO to Present at Upcoming Scientific Conference
04:30pm, Tuesday, 17'th Sep 2024
PLYMOUTH MEETING, Pa. , Sept. 17, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript
03:32am, Friday, 09'th Aug 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacqueline Shea - President & Chi
INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights
04:05pm, Thursday, 08'th Aug 2024
PLYMOUTH MEETING, Pa. , Aug. 8, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rel
